# DESCRIPTION

## TECHNICAL FIELD

- define technical field

## BACKGROUND

- motivate satellite cell proliferation

## SUMMARY

- introduce image-based screen
- describe discovery of compounds
- outline method of inducing proliferation
- describe method of repairing muscle tissue
- outline method of screening compounds

## DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS

- introduce satellite cell proliferation method
- define proliferation
- describe satellite cell characteristics
- discuss satellite cell markers
- describe regulation of satellite cells
- discuss stabilized satellite cells
- introduce kinase inhibitors
- define kinases
- describe types of kinases
- discuss kinase inhibitors
- provide examples of kinase inhibitors

### Kinase Inhibitors

- define kinase inhibitor
- describe types of kinase inhibitors
- introduce FMS-like tyrosine kinase 3 inhibitor
- introduce Aurora kinase inhibitor
- introduce Beta-adrenergic receptor kinase inhibitor
- introduce Check point kinase inhibitor
- introduce Cyclin-dependent kinase 1 inhibitor
- introduce Cyclin-dependent kinase 2 inhibitor
- introduce Cyclin-dependent kinase 4 inhibitor
- introduce Cyclin-dependent kinase inhibitor
- introduce EphB2 kinase inhibitor
- introduce Epidermal growth factor receptor kinase inhibitor
- introduce N-acylmannosamine kinase inhibitor
- introduce MAP kinase inhibitor
- introduce Opheline kinase inhibitor
- introduce Phosphatidylinositol 3-kinase beta inhibitor
- introduce Phosphatidylinositol 3-kinase gamma inhibitor
- introduce Protein kinase (CK1) inhibitor
- introduce Protein kinase B inhibitor
- introduce Protein kinase C eta inhibitor
- introduce Protein-serine-threonine kinase inhibitor
- introduce Proto-oncogene tyrosine-protein kinase Fyn inhibitor
- introduce RET kinase inhibitor

### Hedgehog Signaling Pathway Modulators

- define Hedgehog signaling pathway modulators
- describe Hedgehog pathway components
- explain Hedgehog gain-of-function
- explain patched loss-of-function
- explain Gli gain-of-function
- describe Hedgehog protein structure
- explain Hedgehog signaling mechanism
- describe inactive Hedgehog signaling pathway
- describe active Hedgehog signaling pathway
- explain Hedgehog agonists
- explain Hedgehog antagonists
- list exemplary Hedgehog signaling pathway modulators
- describe modulator effects on Hedgehog pathway
- explain modulator effects on cell proliferation
- describe Hedgehog signaling in cancer
- explain importance of Hedgehog signaling modulation
- summarize Hedgehog signaling pathway modulation

### GPCR Modulators

- define GPCR modulators
- describe GPCR structure
- explain GPCR signaling mechanism
- list GPCR classes
- describe GPCR ligands
- explain GPCR agonists
- explain GPCR antagonists
- list exemplary GPCR modulators
- describe modulator effects on GPCR activity
- explain modulator effects on cell signaling
- describe GPCR modulation in disease
- explain importance of GPCR modulation
- describe GPCR modulator binding
- explain GPCR modulator potency
- describe GPCR modulator selectivity
- explain GPCR modulator efficacy
- summarize GPCR modulation
- conclude GPCR modulator importance

### Dopamine Receptor Modulators

- define dopamine receptor modulator
- introduce dopamine agonist
- introduce dopamine antagonist
- describe dopamine agonist activity
- list exemplary dopamine agonists
- describe dopamine agonist binding
- describe dopamine agonist inhibition
- describe dopamine agonist enhancement
- describe dopamine agonist IC50
- describe dopamine agonist EC50
- introduce beta-3 adrenergic receptor agonists
- list exemplary beta-3 adrenergic receptor agonists
- describe dopamine agonist inhibition of dopamine beta-hydroxylase
- list exemplary inhibitors of dopamine beta-hydroxylase
- describe dopamine beta-hydroxylase inhibition
- describe dopamine beta-hydroxylase inhibitor IC50
- describe dopamine receptor modulator binding
- describe dopamine receptor modulator inhibition
- describe dopamine receptor modulator enhancement
- describe dopamine receptor modulator active site binding
- describe dopamine receptor modulator allosteric site binding
- describe GPCR antagonist IC50
- describe GPCR agonist EC50

### Serotonin Receptor Modulators

- define modulate
- describe serotonin receptors
- list serotonin receptor subtypes
- describe serotonin receptor modulator
- list serotonin receptor modulators
- describe binding of ligand to serotonin receptor
- describe inhibition of serotonin receptor activity
- describe enhancement of serotonin receptor activity
- describe binding to active site of serotonin receptor
- describe binding to allosteric site of serotonin receptor
- describe IC50 of serotonin antagonist
- describe EC50 of serotonin agonist
- describe modulation of serotonin receptor activity
- describe serotonin receptor modulator as agonist or antagonist
- describe serotonin receptor modulator as reversible or irreversible
- describe serotonin receptor modulator as capable of binding to serotonin receptor

### Histamine Receptor Modulators

- define modulate
- describe histamine receptors
- list histamine receptor subtypes
- describe histamine receptor modulator
- list histamine receptor modulators
- describe binding of ligand to histamine receptor
- describe inhibition of histamine receptor activity
- describe enhancement of histamine receptor activity
- describe binding to active site of histamine receptor
- describe binding to allosteric site of histamine receptor
- describe IC50 of histamine antagonist
- describe EC50 of histamine agonist

### HDAC Modulators

- define modulate
- specify modulation percentage
- classify HDACs
- describe Class I HDACs
- describe Class II HDACs
- describe Class III HDACs
- define HDAC modulator
- define HDAC inhibitor
- describe therapeutic effects of HDAC inhibitors
- define selective HDAC inhibitor
- list known HDAC inhibitory compounds
- describe short-chain fatty acid compounds
- describe hydroxyamic acid compounds
- describe cyclic tetrapeptide compounds
- describe benzamide compounds
- describe other HDAC inhibitory compounds
- describe compounds with combined groups
- define HDAC inhibitors
- list HDAC inhibitor examples
- describe HDAC inhibitor derivatives
- introduce non-limiting HDAC inhibitor examples
- describe HDAC inhibitor identification methods
- introduce antisense oligonucleotides and ribozymes
- describe HDAC inhibitor types
- list HDAC inhibitor examples
- describe HDAC modulator effects
- describe HDAC modulator binding capabilities
- describe HDAC antagonist IC50 values
- describe HDAC agonist EC50 values
- introduce HDAC inhibitor commercial availability
- describe HDAC inhibitor patent references
- summarize HDAC modulator embodiments

### Neuropeptides

- define neuropeptides
- list exemplary neuropeptides
- describe characteristics of neuropeptides
- specify embodiments of neuropeptides

### Ionophores

- define ionophore
- describe ionophore function
- list types of ionophores
- exemplify potassium ion ionophores
- exemplify sodium ion ionophores
- exemplify calcium ion ionophores
- exemplify barium ion ionophores
- exemplify chloride ion ionophores
- exemplify bicarbonate ion ionophores
- exemplify ammonium ion ionophores
- exemplify nitrate ion ionophores
- exemplify lithium ion ionophores
- list non-limiting examples of ionophores
- describe ionophore selection
- describe ionophore composition
- describe ionophore combinations
- describe ionophore interactions
- describe ionophore effects
- describe ionophore applications
- describe ionophore advantages
- describe ionophore limitations
- describe ionophore modifications
- describe ionophore derivatives
- describe ionophore analogs
- describe ionophore properties
- describe ionophore structures
- describe ionophore functions
- describe ionophore mechanisms
- describe ionophore interactions
- describe ionophore effects
- describe ionophore applications
- describe ionophore uses
- list beta-blockers
- list K+ ion-channel modulators
- define potassium channel agonist
- list potassium channel agonists
- provide examples of beta-blockers
- provide examples of K+ ion-channel modulators
- list ion-channel modulators
- specify bufalin and its analogs, derivatives, salts, and prodrugs
- provide examples of bufalin analogs and derivatives
- describe bufadienolides and their analogs and derivatives
- reference patents and publications for bufalin analogs and derivatives
- introduce adenosine receptor modulators
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 

## Pharmaceutical Compositions

- define pharmaceutical compositions
- describe therapeutically-effective amount
- introduce pharmaceutically-acceptable carriers
- list examples of carriers
- define repair
- describe therapeutically effective amount
- introduce administration routes
- list examples of administration routes
- define administer
- describe local administration
- describe systemic administration
- introduce transplantation
- describe autotransplantation
- describe allotransplantation
- describe xenotransplantation
- introduce topical formulations
- describe ointments, creams, and powders
- introduce wound dressings and skin coating compositions
- describe administration modes
- list examples of administration modes
- introduce injection and infusion
- describe intravenous infusion or injection
- define subject
- list examples of subjects
- describe patient or subject
- introduce acute myeloid leukemia (AML)
- describe mammal subjects
- introduce domesticated animals and pets
- describe subjects with muscle damage or atrophy
- describe subjects not currently being treated
- describe therapeutic regime adjustment
- introduce diagnosing and selecting subjects
- describe co-administration with pharmaceutically active agents
- list examples of pharmaceutically active agents
- describe growth factors
- introduce dosage forms and amounts
- describe toxicity and therapeutic efficacy

## Screening Assays

- define test compound
- describe test compound types
- provide examples of test compounds
- describe test compound libraries
- provide sources of test compound libraries
- describe solid supports for test compounds
- provide examples of solid supports
- describe group screening
- define satellite cell proliferation enhancement
- provide examples of proliferation enhancement levels
- describe assessing satellite cell proliferation
- describe detecting satellite cell markers
- describe detecting cell replication markers
- provide examples of satellite cell markers
- provide examples of cell replication markers
- describe automated image acquisition and analysis
- describe plating density
- provide examples of plating densities
- describe allowing cells to adhere
- provide examples of adhesion times
- describe changing media
- describe testing compound concentrations
- provide examples of compound concentrations
- describe maintaining satellite cell cultures
- provide examples of culture temperatures
- describe counting satellite cells
- describe counting methods
- describe detecting satellite cell and replication markers
- provide examples of detection times
- describe selecting compounds
- describe additional selection criteria
- describe isolating satellite cells
- describe isolating satellite cells from mammals
- describe transformed satellite cells
- describe high-throughput screening
- describe HTS methods
- describe example assay procedure

## Kits

- define kit for muscle repair or regeneration
- describe kit components
- formulate compound for topical application
- pretreat satellite cells with compound
- include informational material
- describe delivery device
- provide instructions for administration
- provide instructions for identifying suitable subject
- describe formats of informational material
- provide individual components in separate containers
- provide components in one container
- describe combination of components
- include other ingredients in kit
- provide instructions for admixing ingredients
- describe form of compound
- describe purity and sterility of formulation
- describe reconstitution of dried form
- provide solvent in kit
- describe containers for kit
- describe separate containers for formulation and informational material
- describe single container with attached informational material
- provide multiple unit dosage forms in kit
- describe air tight and waterproof containers
- summarize kit embodiments
- introduce methods of increasing satellite cell proliferation
- describe contacting satellite cells with compound
- describe concentration and duration of contacting
- describe in vitro, ex vivo, and in vivo contacting
- describe damaged muscle tissue
- introduce high throughput assay for screening compounds
- describe steps of high throughput assay
- describe detecting cell marker
- describe test compound and assay conditions

### Some Selected Definitions

- define terms and phrases
- provide meanings for convenience
- clarify scope of invention
- define "comprising" and "comprises"
- define singular and plural terms
- define "or" and "about"
- specify percentages and ranges
- define "decrease" and related terms
- define "increase" and related terms
- define "statistically significant"
- define "modulator" and its effects
- define "selective modulator" and "selectively modulates"
- define "target activity"
- define "agonist" and its effects
- define "partial agonist" and its effects
- define "antagonist" and its effects
- define "inhibitor" and related terms
- define "ligand" and "small molecule"

### EXAMPLES

- harvest satellite cells
- isolate cells via FACS
- plate cells in 96-well plates
- add compounds to cells
- incubate cells with compounds
- fix and image plates
- count cell numbers
- score wells for proliferation
- select compounds as hits
- test hits in dose response assay
- validate activity of hits
- re-supply active compounds
- test re-supplied compounds
- identify active compounds
- test CEP701 with bFGF
- examine effect on SMP differentiation
- test CEP701 with TGF-beta inhibitors
- test specificity of CEP701
- test CEP701 in aged tissue
- screen new set of compounds
- identify and validate hits
- test hits with bFGF
- examine effect on SMP differentiation
- test hits with TGF-beta inhibitors
- summarize results of screen
- describe ability of compounds to proliferate SMPs
- describe ability of compounds to differentiate normally
- describe contribution to muscle repair
- harvest satellite cells (Example 2)
- isolate cells via FACS
- plate cells in 96-well plates
- add compounds to cells
- incubate cells with compounds
- fix and image plates
- count cell numbers
- score wells for proliferation
- select compounds as hits
- test hits in dose response assay
- validate activity of hits
- describe ability of compounds to expand human satellite cells
- describe ability of compounds to drive myoblast differentiation
- describe ability of compounds to enhance engraftability

